100 related articles for article (PubMed ID: 18583176)
1. The midbrain slice preparation. An in vitro model to select potential anti-parkinsonian drugs?
Guatteo E; Cucchiaroni ML; Sebastianelli L; Bernardi G; Mercuri NB
Parkinsonism Relat Disord; 2008; 14 Suppl 2():S150-3. PubMed ID: 18583176
[TBL] [Abstract][Full Text] [Related]
2. Actions of methylphenidate on dopaminergic neurons of the ventral midbrain.
Federici M; Geracitano R; Bernardi G; Mercuri NB
Biol Psychiatry; 2005 Feb; 57(4):361-5. PubMed ID: 15705351
[TBL] [Abstract][Full Text] [Related]
3. The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area.
Mercuri NB; Calabresi P; Bernardi G
Life Sci; 1992; 51(10):711-8. PubMed ID: 1355254
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic activation excites rat lateral habenular neurons in vivo.
Kowski AB; Veh RW; Weiss T
Neuroscience; 2009 Jul; 161(4):1154-65. PubMed ID: 19374940
[TBL] [Abstract][Full Text] [Related]
5. Tranylcypromine, but not moclobemide, prolongs the inhibitory action of dopamine on midbrain dopaminergic neurons: an in vitro electrophysiological study.
Mercuri NB; Federici M; Marinelli S; Bernardi G
Synapse; 2000 Sep; 37(3):216-21. PubMed ID: 10881043
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
Shin JY; Park HJ; Ahn YH; Lee PH
J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
[TBL] [Abstract][Full Text] [Related]
7. On the effects of psychostimulants, antidepressants, and the antiparkinsonian drug levodopa on dopamine neurons.
Geracitano R; Federici M; Bernardi G; Mercuri NB
Ann N Y Acad Sci; 2006 Aug; 1074():320-9. PubMed ID: 17105928
[TBL] [Abstract][Full Text] [Related]
8. Dopamine release in organotypic cultures of foetal mouse mesencephalon: effects of depolarizing agents, pargyline, nomifensine, tetrodotoxin and calcium.
Larsen TR; Rossen S; Gramsbergen JB
Eur J Neurosci; 2008 Aug; 28(3):569-76. PubMed ID: 18702728
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dopaminergic system to D-amphetamine: involvement of the D1-regulated feedback control of midbrain dopamine neurons.
Sotty F; Montezinho LP; Steiniger-Brach B; Nielsen J
J Neurochem; 2009 May; 109(3):766-75. PubMed ID: 19236563
[TBL] [Abstract][Full Text] [Related]
10. Multiple mechanisms underlie burst firing in rat midbrain dopamine neurons in vitro.
Johnson SW; Wu YN
Brain Res; 2004 Sep; 1019(1-2):293-6. PubMed ID: 15306267
[TBL] [Abstract][Full Text] [Related]
11. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism.
Ballion B; Frenois F; Zold CL; Chetrit J; Murer MG; Gonon F
Neurobiol Dis; 2009 Sep; 35(3):376-84. PubMed ID: 19501163
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling.
Katsuki H; Kurimoto E; Takemori S; Kurauchi Y; Hisatsune A; Isohama Y; Izumi Y; Kume T; Shudo K; Akaike A
J Neurochem; 2009 Jul; 110(2):707-18. PubMed ID: 19457078
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor administered in the periphery influences excitatory synaptic inputs onto midbrain dopaminergic neurons in postnatal mice.
Namba H; Zheng Y; Abe Y; Nawa H
Neuroscience; 2009 Feb; 158(4):1731-41. PubMed ID: 19041374
[TBL] [Abstract][Full Text] [Related]
14. Individual dopamine midbrain neurons: functional diversity and flexibility in health and disease.
Liss B; Roeper J
Brain Res Rev; 2008 Aug; 58(2):314-21. PubMed ID: 18023878
[TBL] [Abstract][Full Text] [Related]
15. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
Monti JM; Jantos H
Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
[TBL] [Abstract][Full Text] [Related]
16. Ethanol enhances GABAB-mediated inhibitory postsynaptic transmission on rat midbrain dopaminergic neurons by facilitating GIRK currents.
Federici M; Nisticò R; Giustizieri M; Bernardi G; Mercuri NB
Eur J Neurosci; 2009 Apr; 29(7):1369-77. PubMed ID: 19309316
[TBL] [Abstract][Full Text] [Related]
17. Influence of dopaminergic anti-Parkinsonian agents on inflammatory reactions in rats.
Hirschelmann R; Thong NT
Pharmazie; 2000 Jun; 55(6):469. PubMed ID: 10907263
[No Abstract] [Full Text] [Related]
18. The multiple actions of selegiline.
Ebadi M; Sharma S; Shavali S; Sangchot P; Brekke L
Proc West Pharmacol Soc; 2002; 45():39-41. PubMed ID: 12434521
[No Abstract] [Full Text] [Related]
19. Midbrain dopamine system electrophysiological functioning: a review and new hypothesis.
Bunney BS; Chiodo LA; Grace AA
Synapse; 1991 Oct; 9(2):79-94. PubMed ID: 1821487
[TBL] [Abstract][Full Text] [Related]
20. Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization.
Guerreiro S; Ponceau A; Toulorge D; Martin E; Alvarez-Fischer D; Hirsch EC; Michel PP
J Neurochem; 2009 May; 109(4):1118-28. PubMed ID: 19302482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
